- Home
- IPSC vs PNF Comparison
IPSC vs PNF Comparison
Compare IPSC & PNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- PNF
- Stock Information
- Founded
- IPSC 2019
- PNF 2001
- Country
- IPSC United States
- PNF United States
- Employees
- IPSC N/A
- PNF N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- PNF Finance Companies
- Sector
- IPSC Health Care
- PNF Finance
- Exchange
- IPSC Nasdaq
- PNF Nasdaq
- Market Cap
- IPSC 49.6M
- PNF 54.9M
- IPO Year
- IPSC 2021
- PNF N/A
- Fundamental
- Price
- IPSC $0.56
- PNF $7.01
- Analyst Decision
- IPSC Strong Buy
- PNF
- Analyst Count
- IPSC 5
- PNF 0
- Target Price
- IPSC $3.33
- PNF N/A
- AVG Volume (30 Days)
- IPSC 1.2M
- PNF 29.1K
- Earning Date
- IPSC 08-07-2025
- PNF 01-01-0001
- Dividend Yield
- IPSC N/A
- PNF 5.17%
- EPS Growth
- IPSC N/A
- PNF N/A
- EPS
- IPSC N/A
- PNF N/A
- Revenue
- IPSC $114,898,000.00
- PNF N/A
- Revenue This Year
- IPSC $1,064.82
- PNF N/A
- Revenue Next Year
- IPSC N/A
- PNF N/A
- P/E Ratio
- IPSC N/A
- PNF N/A
- Revenue Growth
- IPSC 8286.72
- PNF N/A
- 52 Week Low
- IPSC $0.34
- PNF $6.37
- 52 Week High
- IPSC $3.29
- PNF $9.06
- Technical
- Relative Strength Index (RSI)
- IPSC 46.47
- PNF 54.74
- Support Level
- IPSC $0.52
- PNF $6.89
- Resistance Level
- IPSC $0.60
- PNF $7.02
- Average True Range (ATR)
- IPSC 0.04
- PNF 0.07
- MACD
- IPSC -0.01
- PNF 0.01
- Stochastic Oscillator
- IPSC 25.19
- PNF 77.50
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About PNF PIMCO New York Municipal Income Fund
PIMCO New York Municipal Income Fund is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund's portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.